Page last updated: 2024-09-03

mk 0663 and Intestinal Perforation

mk 0663 has been researched along with Intestinal Perforation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolognese, JA; Curtis, SP; Ramey, DR; Reicin, AS; Watson, DJ; Yu, C	1

Reviews

1 review(s) available for mk 0663 and Intestinal Perforation

Article	Year
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Etoricoxib; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Incidence; Intestinal Perforation; Peptic Ulcer; Proportional Hazards Models; Pyridines; Randomized Controlled Trials as Topic; Sulfones	2005

Article

Year

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.

Current medical research and opinion, 2005, Volume: 21, Issue:5

Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Etoricoxib; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Incidence; Intestinal Perforation; Peptic Ulcer; Proportional Hazards Models; Pyridines; Randomized Controlled Trials as Topic; Sulfones

2005